{"DataElement":{"publicId":"2778189","version":"1","preferredName":"Patient Prior Registration Laboratory Procedure Eligibility Determination Ind-2","preferredDefinition":"the yes/no indicator whether a medical procedure that involves testing a sample of blood, urine, or other substance from a person who receives medical attention, care, or treatment prior to the act of enrolling on a clinical trial was performed as part of the determination of the suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"PT_P_REG_LAB_ELG_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2778188","version":"1","preferredName":"Patient Prior Registration Laboratory Procedure Eligibility Determination","preferredDefinition":"information related to the medical procedure that involves testing a sample of blood, urine, or other substance from a person who receives medical attention, care, or treatment prior to the act of enrolling on a clinical trial as a determination of the suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"PT_P_REG_LAB_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778186","version":"1","preferredName":"Prior Registration Laboratory Procedure Eligibility Determination","preferredDefinition":"Earlier in time or order.:Registration; the act of enrolling.:A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C25629:C25646:C25294:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Registration","conceptCode":"C25646","definition":"The act of listing or recording officially; officially qualified or enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55726A7F-C1C1-12FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55726A7F-C1D2-12FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"},{"publicId":"6540049","version":"1","longName":"SSPedi (Symptom Screening in Pediatrics)","context":"COG"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3314494","version":"1","longName":"Labs","context":"ECOG-ACRIN"},{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104893","version":"1","longName":"GOG-0230D","context":"NRG"}]}],"AlternateNames":[{"name":"PT_P_REG_LAB_ELG_IND","type":"USED_BY","context":"CTEP"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PT_P_REG_LAB_ELG_IND","type":"USED_BY","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"PT_P_REG_LAB_ELG_IND","type":"USED_BY","context":"NRG"},{"name":"PT_P_REG_LAB_ELG_IND","type":"USED_BY","context":"CITN"},{"name":"PT_P_REG_LAB_ELG_IND","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"The following laboratory valu","type":"Preferred Question Text","description":"The following laboratory values obtained <=7 days prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Pretreatment tests/procedures must be completed <= 7 days prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Adequate bone marrow, hepatic and renal function prior to registration","url":null,"context":"CTEP"},{"name":"CRF1 Text","type":"Alternate Question Text","description":"Physical examination, rectal examination and transrectal ultrasound have been done within 6 months prior to randomization and radiographic studies, if indicated, are negative for metastasis","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Adequate hepatic function must be met as evidenced by total serum bilirubin <= 1.5 mg/dL (patients with total bilirubin >1.5 mg/dL eligible only with Gilbert's syndrome); alkaline phosphatase <2.5 times the upper limit of normal; and/or, SGOT (AST) <1.5 times upper limit of normal [alkaline phosphatase and SGOT (AST) cannot both exceed the upper limit of normal]","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"The following laboratory values obtained <= 14 days prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Within 3 months prior to entry, the patient must have a baseline left ventricular ejection fraction (LVEF) measured by MUGA scan >= 55","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"The following laboratory values obtained <=15 days prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Does the patient have both bilirubin and AST/ALT greater than ULN?","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Were tests to determine eligibility performed during the indicated period","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"The following laboratory values obtained <= 28 days prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"The following laboratory values obtained <= 21 days prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text13","type":"Alternate Question Text","description":"The following laboratory values obtained within 7 days of first CYT107 injection","url":null,"context":"CTEP"},{"name":"ACRIN 6690","type":"Alternate Question Text","description":"Has the participant's bilirubin level been shown to be higher than 3.0 mg/dL within the past 28 days prior to enrollment?","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days prior to enrollment?","url":null,"context":"COG"},{"name":"COG CRF TEXT 2","type":"Alternate Question Text","description":"Were all clinical and laboratory studies performed within 7 days prior to enrollment?","url":null,"context":"COG"},{"name":"CRF Text 14","type":"Alternate Question Text","description":"The following eligibility laboratory values were obtained <= 30 days prior to registration on study","url":null,"context":"NRG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days prior to enrollment?","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 14 days prior to enrollment?","url":null,"context":"CTEP"},{"name":"ALT 1","type":"Alternate Question Text","description":"Were the following laboratory values obtained within 2 weeks prior to registration?","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days prior to enrollment unless otherwise indicated?","url":null,"context":"CTEP"},{"name":"EAF151 Text","type":"Alternate Question Text","description":"Does the patient have adequate organ function, including adequate renal function defined as eGFR greater than or equal to 40 mL/min/1.73m2 as calculated per institution standard of care, and meeting local site requirements for intravenous administration of gadolinium-based MRI contrast agents?","url":null,"context":"ECOG-ACRIN"},{"name":"EAI141 CRF","type":"Alternate Question Text","description":"Does participant have adequate organ function, including adequate renal function defined as eGFR greater than or equal to 40 mL/min/1.73m2 as calculated per institution standard of care, and meeting local site requirements for intravenous administration of gadolinium-based MRI contrast agents?","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days prior to study enrollment?","url":null,"context":"COG"},{"name":"COG CRF text 7","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days of starting systemic therapy unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 20","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days of starting protocol-directed systemic therapy unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Were tests to determine eligibility performed during the indicated period?","url":null,"context":"COG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Were all clinical studies (e.g. cardiac imaging, pulmonary function tests, if applicable), obtained within 21 days prior to enrollment?","url":null,"context":"COG"},{"name":"COG CRF Text","type":"Alternate Question Text","description":"Were all laboratory studies to determine eligibility performed within 7 days prior to enrollment?","url":null,"context":"COG"},{"name":"Were all clinical and laboratory studies to determine eligibility performed within 21 days prior to enrollment and start of protocol therapy (repeat if necessary) unless otherwise indicated?","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 21 days prior to enrollment and start of protocol therapy (repeat if necessary) unless otherwise indicated?","url":null,"context":"COG"},{"name":"Were disease/staging imaging studies to determine eligibility performed within 3 days prior to enrollment and within 28 days prior to the projected surgery date?","type":"Alternate Question Text","description":"Were disease/staging imaging studies to determine eligibility performed within 3 days prior to enrollment and within 28 days prior to the projected surgery date?","url":null,"context":"COG"},{"name":"Were all clinical and laboratory studies, if applicable, performed within 21 days prior to enrollment and start of protocol therapy (repeat if necessary) unless otherwise indicated?","type":"Alternate Question Text","description":"Were all clinical and laboratory studies, if applicable, performed within 21 days prior to enrollment and start of protocol therapy (repeat if necessary) unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Were all clinical studies (eg, cardiac imaging, pulmonary function tests, bilateral BMA/BX and CSF analysis), if applicable, obtained within 28 days prior to enrollment and start of protocol therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Were all clinical studies (eg, cardiac imaging, pulmonary function tests, bilateral BMA/BX and CSF analysis), if applicable, obtained within 28 days prior to enrollment and start of protocol therapy unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Were all laboratory studies to determine eligibility performed within 7 days prior to enrollment and start of protocol therapy unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Were all disease/staging imaging studies to determine eligibility performed within 28 days prior to enrollment and start of protocol therapy unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 23","type":"Alternate Question Text","description":"Were all of the treatment eligibility criteria to begin HCT conditioning regimen performed within 4 weeks of starting this therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 14","type":"Alternate Question Text","description":"Were all laboratory studies to determine eligibility performed within 7 days prior to enrollment unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 15","type":"Alternate Question Text","description":"Were all disease/staging imaging studies obtained  within 28 days prior to enrollment and start of protocol therapy?","url":null,"context":"COG"},{"name":"Were all clinical and laboratory studies to determine eligibility performed within 7 days prior to enrollment unless otherwise indicated?","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 7 days prior to enrollment unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 24","type":"Alternate Question Text","description":"Were all of the treatment criteria to begin HCT conditioning regimen performed within 4 weeks of starting this therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 21","type":"Alternate Question Text","description":"Were all clinical studies (eg, cardiac imaging, pulmonary function tests), if applicable, obtained within 28 days prior to start of protocol therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 22","type":"Alternate Question Text","description":"Were all disease/staging imaging studies, if applicable, obtained within 28 days prior to start of protocol therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 25","type":"Alternate Question Text","description":"Were all disease/staging imaging studies obtained within 28 days prior to enrollment and start of protocol therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 13","type":"Alternate Question Text","description":"Were all clinical and laboratory studies to determine eligibility performed within 14 days prior to enrollment unless otherwise indicated?","url":null,"context":"COG"},{"name":"COG CRF Text 16","type":"Alternate Question Text","description":"Are all laboratory studies to determine eligibility performed within 7 days prior to enrollment?","url":null,"context":"COG"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5572724F-9156-1450-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"KUMMEROA","dateModified":"2023-03-06","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.3.6 AQT added per ticket request CADSR0002119. ak 2022.10.4 AQT added for ticket request CADSR0001571. ak","unresolvedIssues":null,"deletedIndicator":"No"}}